Zimbabwe has declined a significant American health deal valued at $367m (£272m) spanning five years over Washington's insistence on confidential data.
This rejection became public following a internal memorandum from December was disclosed, which showed Head of State Emmerson Mnangagwa felt the deal was "unbalanced".
A government spokesperson later stated that the US was demanding access to biological samples for scientific study and commercial gain while refused to guarantee the resulting advantages from any future vaccines.
"We will now turn to the challenging and unfortunate task of ending our health aid in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont in a statement.
The US Embassy said the US had furnished more than $1.9bn in health funding to Zimbabwe during the past two decades.
A doctors' association in Zimbabwe has called for more negotiations to find a deal acceptable to all parties so the nation's vital HIV treatment initiative can be sustained.
Wider Context
This rejection follows a comparable situation in Kenya, where a court halted a similar deal with the US after legal challenges were raised about the safety of Kenyans' health data.
After resuming the presidency last year, US President Donald Trump has reduced overseas assistance and shut down the US Agency for International Development (USAID).
The agency had administered aid for the US government, but Trump stated its spending was "wasteful" and his government was pursuing government-to-government agreements to enhance transparency and accountability.
As per reports, 16 nations in Africa have to date agreed to these new health pacts, constituting more than $18.3bn in new funding.
Specifics of the Declined Agreement
The funds for Zimbabwe was intended to gone towards "combating HIV/Aids, TB, malaria, healthcare for mothers and children, and preparing for epidemics".
"We believe this partnership might have yielded significant benefits for the people of Zimbabwe, particularly the 1.2 million men, women and children presently receiving antiretroviral therapy through US-supported initiatives," the Ambassador said.
However, official spokesman Nick Mangwana argued the proposed deal was "unequal".
"Our nation was requested to surrender its genetic material and health information indefinitely, without any equivalent guarantee of access to any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that might result from that provided information," Mangwana explained.
"Put simply, our nation would supply the basic resources for medical research without any assurance that the end products would be available to our people should a future pandemic arise."
Sovereignty and Global Health
He also pointed out that the US's withdrawal from the World Health Organization (WHO) and its push of one-on-one health agreements were undermining structures previously set up via the international organization.
Mangwana gave as an example its Pathogen Access and Benefit Sharing system designed to deal with future pandemics.
"This system is designed to ensure that when a nation provides its data, the resulting advantages – including vaccines and treatments – are distributed fairly, not commercialised exclusively by those with the capability to develop them."
The government's concerns over the US deal "should not be misconstrued as hostility towards the US," Mangwana stressed.
"We are open to ongoing dialogue with our US partners on how subsequent collaboration could be designed in a manner that honours the independence and interests of both nations."
Health Experts Response
A leading public health body stated it understood the official position, but suggested that talks must proceed since much of the country's Aids initiatives were funded by foreign aid.
"In cases where specific concerns exist, including those relating to information security or agreement terms, these can frequently be addressed via detailed discussion and negotiated safeguards," the group added.
The halted deal underscores the continuing challenges between accepting crucial international aid and safeguarding local interests in an ever more interconnected world.